Wang Yinxia, Xing Ligang
Department of Radiation Oncology, The Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Pain Res Manag. 2020 Jan 30;2020:7565962. doi: 10.1155/2020/7565962. eCollection 2020.
Radiotherapy is commonly used to treat cancer patients. Besides the curable effect, radiotherapy also could relieve the pain of cancer patients. However, cancer pain is gradually alleviated about two weeks after radiotherapy. In addition, cancer patients who receive radiotherapy may also suffer from pain flare or radiotherapy-induced side effects such as radiation esophagitis, enteritis, and mucositis. Pain control is reported to be inadequate during the whole course of radiotherapy (before, during, and after radiotherapy), and quality of life is seriously affected. Hence, radiotherapy is suggested to be combined with analgesic drugs in clinical guidelines. Previous studies have shown that radiotherapy combined with oxycodone hydrochloride can effectively alleviate cancer pain. In this review, we firstly presented the necessity of analgesia during the whole course of radiotherapy. We also sketched the role of oxycodone hydrochloride in radiotherapy of bone metastases and radiotherapy-induced oral mucositis. Finally, we concluded that oxycodone hydrochloride shows good efficacy and tolerance and could be used for pain management before, during, and after radiotherapy.
放射疗法常用于治疗癌症患者。除了具有治愈效果外,放射疗法还能缓解癌症患者的疼痛。然而,癌症疼痛在放疗后约两周才会逐渐减轻。此外,接受放射治疗的癌症患者还可能遭受疼痛加剧或放疗引起的副作用,如放射性食管炎、肠炎和粘膜炎。据报道,在放疗的整个过程(放疗前、放疗期间和放疗后)疼痛控制不足,生活质量受到严重影响。因此,临床指南建议放射疗法与镇痛药联合使用。先前的研究表明,放射疗法联合盐酸羟考酮可有效缓解癌症疼痛。在本综述中,我们首先阐述了放疗全程镇痛的必要性。我们还概述了盐酸羟考酮在骨转移瘤放疗和放疗引起的口腔粘膜炎中的作用。最后,我们得出结论,盐酸羟考酮显示出良好的疗效和耐受性,可用于放疗前、放疗期间和放疗后疼痛管理。